M&T Bank Corp Orchard Therapeutics PLC Transaction History

M&T Bank Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 29, 2020	SELL	$5.75 - $11.99 $101,867 - $212,414	-17,716 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$5.65 - $15.71 $13,593 - $37,798	2,406 Added 15.72%	17,716 $133,000
Q4 2019 Feb 07, 2020	BUY	$10.15 - $15.58 $26,775 - $41,100	2,638 Added 20.82%	15,310 $211,000
Q3 2019 Nov 12, 2019	BUY	$11.88 - $16.72 $21,395 - $30,112	1,801 Added 16.57%	12,672 $151,000
Q1 2019 May 15, 2019	BUY	$12.01 - $19.49 $130,560 - $211,875	10,871 New	10,871 $194,000

545K

Ticker ORTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,458,000
Description
Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

Stay updated on M&T Bank Corp with notifications on news.